UK - PanOpSys Ltd receives $5.25m Quester funding

The company’s patented piezoelectric film technology works with whole blood samples and does not require membranes for red cell separation or lateral flow detection. Tests are performed on a small format device together with disposable strips with the sensitivity and precision normally only seen on large laboratory analysers. The immuno-assay technology can be packaged as professional systems for detecting wide panels of tests in both hospitals and primary care, or as compact consumer products for personal at home diagnostics.

The core technology is readily applicable to a wide variety of tests and the scope for new products is significant. At this stage the company remains focused on the commercial development of its in-house tests, but is also in discussion with various diagnostic companies about other development, manufacturing and marketing opportunities.

The company recently relocated to a new purpose designed facility at the Kent Science Park.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Early-stage
• UK / Ireland